[A Case of Remnant Gastric Cancer with Mesojejunal Lymph Node Metastasis].

Autor: Sasaki H; Dept. of Surgery, Tohoku University Graduate School of Medicine., Aoki T, Yamamura A, Tanaka N, Imoto H, Tsuchiya T, Kawana T, Morikawa T, Ohnuma S, Kamei T, Unno M
Jazyk: japonština
Zdroj: Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2021 Dec; Vol. 48 (13), pp. 2118-2120.
Abstrakt: A 62-year-old man underwent radical surgery for the treatment of remnant gastric cancer with mesojejunal lymph node metastasis. According to the 15th edition of the Japanese Gastric Cancer Association, a histological diagnosis of B-35-A, type 3, tub2>tub1, pT3(SS), pN3a(10/37), cM0, CY0, pStage ⅢB was made. All lymph node metastases were recognized in the mesojejunum. Adjuvant chemotherapy with S-1 plus docetaxel was initiated after 4 weeks of surgery. The patient is still alive without recurrence after 1 year of surgery. Thus, radical surgery with dissection of the mesojejunum and intensive adjuvant chemotherapy might improve the prognosis in a remnant gastric cancer patient with mesojejunal lymph node metastasis.
Databáze: MEDLINE